SCHEMBL17060892

SCHEMBL17060892

CCOCC(CC)C(=O)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.34
MAPK1 P28482 1/20 0.34
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
TSHR P16473 3/20 0.32
USP2 O75604 1/20 0.32
CA1 P00915 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CHRM1 P11229 1/20 0.30
AKR1A1 P14550 1/20 0.30
CHRM3 P20309 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
ADRA1A P35348 1/20 0.30
HRH1 P35367 1/20 0.30
DRD3 P35462 1/20 0.30
SLC6A3 Q01959 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL169923 0.82 CA2 (0.46) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL60732 0.82 CA2 (0.46) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL3018124 0.80 CA2 (0.36) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL165103 0.78 CA2 (0.44) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL8399233 0.77 TSHR (0.31) CA2TSHRUSP2CA1ALDH1A1
Ethylene Glycol SCHEMBL5068932 0.77 CA2 (0.42) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL18065074 0.76 ALDH1A1 (0.40) CA2TSHRUSP2CA1ALDH1A1
SCHEMBL2943135 0.74 CA1 (0.53) CA2TSHRUSP2CA1ALDH1A1
Hydrochloric Acid SCHEMBL11604562 0.74 CA2 (0.47) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL11022453 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874407-B1 SUBSTANCES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF GLYOXALASES AND THEIR USE AS ANTI-FUNGAL AGENTS BIOMAC PRIVATINSTITUT FÜR MEDIZINISCHE UND ZAHNMEDIZINISCHE FORSCHUNG ENTWICKLUNG UND DIAGNOSTIK GMB (DE) 2015-09-09 EP disclosed